Ryotaro Asano

13PUBLICATIONS
36CO-AUTHORS
Epidemiological modellingMedical infection agents (incl. prions)Systems physiologyRespiratory diseasesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 29, 2026
Real-world analysis on hemodynamic effectiveness and adverse events of selexipag in pulmonary arterial hypertension.

|Aug 27, 2026
Pulmonary Arterial Hypertension With Moyamoya Disease Harboring the RNF213 p.Arg4810Lys Variant Presenting a Favorable Response to Monotherapy: A Case Report.

|Mar 26, 2026
Pulmonary Arterial Hypertension-Specific Therapy for Atrial Septal Defects with Severe Pulmonary Arterial Hypertension.

Sayuri Nakayama, Ryotaro Asano, Akihiro Tsuji

|Feb 23, 2026
Pulmonary Venous Vasculopathy in Connective Tissue Disease-Associated Pulmonary Arterial Hypertension With Reduced Diffusion Capacity for Carbon Monoxide.

Shinya Fujisaki, Ryotaro Asano, Hiroyuki Endo

|Nov 20, 2025
Long-term outcome of patients with Eisenmenger syndrome receiving pulmonary arterial hypertension-targeted therapy.

Hideo Matama, Ryotaro Asano, Hiroyuki Endo

|Sep 05, 2025
Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.

Ryo Takano, Tatsuo Aoki, Shinya Fujisaki

Pageof 3

Frequent Collaborators

9 joint publications

Takeshi Ogo

6 joint publications

Yoshikazu Nakaoka

5 joint publications

Tomohiko Ishibashi

4 joint publications

Shinya Fujisaki